Form D · Other
Sunrise Genetics Inc.
Fort Collins, CO · CIK 0001776858
Offering snapshot reported Feb 11, 2020 · SEC filing
- Reported sold
- $379K Offering amount: $379K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Jan 28, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2020 | Initial | $378,619 | No comparison | 3 | SEC filing |
| May 28, 2019 | Initial | $750,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-360202
Source: Form D, filed Feb 11, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matt Gibbs | Director, Executive |
| Bob Gibbs | Director |
| Jason Schwartz | Director, Executive |
| Cj Schwartz | Director, Executive |
| Christopher J Schwartz | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1821 Busch Court
Fort Collins, CO, 80525
Fort Collins, CO, 80525